These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1400423

  • 1. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC, Leban JJ, Landavazo A, Stewart KD, Stockstill B, McDermed JD.
    J Biol Chem; 1992 Oct 15; 267(29):21132-8. PubMed ID: 1400423
    [Abstract] [Full Text] [Related]

  • 2. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
    Leban JJ, Kull FC, Landavazo A, Stockstill B, McDermed JD.
    Proc Natl Acad Sci U S A; 1993 Mar 01; 90(5):1922-6. PubMed ID: 8446610
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH, Taylor JE, Jiang NY, Kim SH, Wang LH, Huang SC, Moreau JP, Gardner JD, Jensen RT.
    J Biol Chem; 1989 Sep 05; 264(25):14691-7. PubMed ID: 2475489
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
    Woll PJ, Coy DH, Rozengurt E.
    Biochem Biophys Res Commun; 1988 Aug 30; 155(1):359-65. PubMed ID: 2843183
    [Abstract] [Full Text] [Related]

  • 7. Covalently cyclized agonist and antagonist analogues of bombesin and related peptides.
    Coy DH, Jiang NY, Kim SH, Moreau JP, Lin JT, Frucht H, Qian JM, Wang LW, Jensen RT.
    J Biol Chem; 1991 Sep 05; 266(25):16441-7. PubMed ID: 1715866
    [Abstract] [Full Text] [Related]

  • 8. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
    Pinski J, Yano T, Groot K, Cai RZ, Radulovic S, Schally AV.
    Am J Physiol; 1992 Oct 05; 263(4 Pt 1):E712-7. PubMed ID: 1415689
    [Abstract] [Full Text] [Related]

  • 9. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY, Schonbrunn A.
    Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345
    [Abstract] [Full Text] [Related]

  • 10. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB, Hildebrand P, Jeker LB, Pansky A, Eberle AN, Beglinger C.
    Regul Pept; 1994 Oct 21; 53(3):165-73. PubMed ID: 7531356
    [Abstract] [Full Text] [Related]

  • 11. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S, Spindel ER, Rubin NH, Singh P.
    Cell Growth Differ; 1992 Feb 21; 3(2):111-8. PubMed ID: 1323998
    [Abstract] [Full Text] [Related]

  • 12. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
    Cai RZ, Radulovic S, Pinski J, Nagy A, Redding TW, Olsen DB, Schally AV.
    Peptides; 1992 Feb 21; 13(2):267-71. PubMed ID: 1409006
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT, Coy DH, Mantey SA, Jensen RT.
    J Pharmacol Exp Ther; 1995 Oct 21; 275(1):285-95. PubMed ID: 7562561
    [Abstract] [Full Text] [Related]

  • 15. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH, Battey JF, Wada E, Lin JT, Mantey S, Coy DH, Jensen RT.
    Biochem J; 1992 Sep 01; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S, Guo YS, Townsend CM, Singh P.
    Cancer Res; 1990 Nov 01; 50(21):6772-8. PubMed ID: 2208141
    [Abstract] [Full Text] [Related]

  • 18. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM, Hoang DO, Feldman RI.
    Mol Pharmacol; 1995 Apr 01; 47(4):871-81. PubMed ID: 7723750
    [Abstract] [Full Text] [Related]

  • 19. A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.
    Oiry C, Pannequin J, Bernad N, Artis AM, Galleyrand JC, Devin C, Cristau M, Fehrentz JA, Martinez J.
    Eur J Pharmacol; 2000 Sep 01; 403(1-2):17-25. PubMed ID: 10969139
    [Abstract] [Full Text] [Related]

  • 20. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue.
    Camble R, Cotton R, Dutta AS, Garner A, Hayward CF, Moore VE, Scholes PB.
    Life Sci; 1989 Sep 01; 45(17):1521-7. PubMed ID: 2555638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.